BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33905978)

  • 1. Magnetic resonance imaging and diffusion-weighted imaging-based histogram analyses in predicting glypican 3-positive hepatocellular carcinoma.
    Zhao J; Gao S; Sun W; Grimm R; Fu C; Han J; Sheng R; Zeng M
    Eur J Radiol; 2021 Jun; 139():109732. PubMed ID: 33905978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative image features of gadoxetic acid-enhanced MRI for predicting glypican-3 expression of small hepatocellular carcinoma ≤3 cm.
    Dong SY; Sun W; Xu B; Wang WT; Yang YT; Chen XS; Zeng MS; Rao SX
    Clin Radiol; 2023 Oct; 78(10):e764-e772. PubMed ID: 37500336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3-Positive Hepatocellular Carcinoma.
    Gu D; Xie Y; Wei J; Li W; Ye Z; Zhu Z; Tian J; Li X
    J Magn Reson Imaging; 2020 Dec; 52(6):1679-1687. PubMed ID: 32491239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
    Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
    Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and
    Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
    World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics on Gadoxetate Disodium-enhanced MRI: Non-invasively Identifying Glypican 3-Positive Hepatocellular Carcinoma and Postoperative Recurrence.
    Chong H; Gong Y; Zhang Y; Dai Y; Sheng R; Zeng M
    Acad Radiol; 2023 Jan; 30(1):49-63. PubMed ID: 35562264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Hepatocellular Carcinoma.
    Zou X; Luo Y; Li Z; Hu Y; Li H; Tang H; Shen Y; Hu D; Kamel IR
    J Magn Reson Imaging; 2019 Apr; 49(4):975-983. PubMed ID: 30277628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric MRI combined with clinical factors to predict glypican-3 expression of hepatocellular carcinoma.
    Liu P; Li W; Qiu G; Chen J; Liu Y; Wen Z; Liang M; Zhao Y
    Front Oncol; 2023; 13():1142916. PubMed ID: 38023195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.
    Chen J; Wu Z; Xia C; Jiang H; Liu X; Duan T; Cao L; Ye Z; Zhang Z; Ma L; Song B; Shi Y
    Eur Radiol; 2020 Feb; 30(2):1232-1242. PubMed ID: 31529254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric quantitative histogram analysis using diffusion-weighted magnetic resonance imaging to differentiate HCC from other primary liver cancers.
    Lewis S; Peti S; Hectors SJ; King M; Rosen A; Kamath A; Putra J; Thung S; Taouli B
    Abdom Radiol (NY); 2019 Mar; 44(3):912-922. PubMed ID: 30712136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting glypican-3 expression in hepatocellular carcinoma: A comprehensive analysis using combined contrast-enhanced ultrasound and clinical factors.
    Li N; Dong T; Wang P; Li Q; Nie F
    Clin Hemorheol Microcirc; 2023; 85(4):407-420. PubMed ID: 37638421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging and diffusion-weighted MR imaging in predicting microvascular invasion in hepatocellular carcinoma and the prognostic significance].
    Zhu YJ; Feng B; Wang BZ; Wang S; Ye F; Ma XH; Zhao XM
    Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):312-317. PubMed ID: 33752311
    [No Abstract]   [Full Text] [Related]  

  • 13. Preoperative histogram analysis of intravoxel incoherent motion (IVIM) for predicting microvascular invasion in patients with single hepatocellular carcinoma.
    Li H; Zhang J; Zheng Z; Guo Y; Chen M; Xie C; Zhang Z; Mei Y; Feng Y; Xu Y
    Eur J Radiol; 2018 Aug; 105():65-71. PubMed ID: 30017300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.
    Chen J; Xia C; Duan T; Cao L; Jiang H; Liu X; Zhang Z; Ye Z; Wu Z; Gao R; Shi Y; Song B
    Eur Radiol; 2021 Oct; 31(10):7696-7704. PubMed ID: 33856520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of microvascular invasion of hepatocellular carcinoma with preoperative diffusion-weighted imaging: A comparison of mean and minimum apparent diffusion coefficient values.
    Zhao J; Li X; Zhang K; Yin X; Meng X; Han L; Zhang X
    Medicine (Baltimore); 2017 Aug; 96(33):e7754. PubMed ID: 28816952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging.
    Zhang N; Wu M; Zhou Y; Yu C; Shi D; Wang C; Gao M; Lv Y; Zhu S
    Front Oncol; 2023; 13():1209814. PubMed ID: 37841420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Imaging and Diffusion Weighted Imaging-Based Histogram in Predicting Mesenchymal Transition High-Grade Serous Ovarian Cancer.
    Cai SQ; Song ZY; Wu MR; Lu JJ; Sun WW; Wei F; Li HM; Qiang JW; Li YA; Zhu J; Zhou JJ; Zeng MS
    Acad Radiol; 2023 Jun; 30(6):1118-1128. PubMed ID: 35909051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance texture analysis for the identification of cytokeratin 19-positive hepatocellular carcinoma.
    Wang HQ; Yang C; Zeng MS; Rao SX; Ji Y; Weng X; Wang JY; Sheng RF
    Eur J Radiol; 2019 Aug; 117():164-170. PubMed ID: 31307643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging?
    Xu P; Zeng M; Liu K; Shan Y; Xu C; Lin J
    J Gastroenterol Hepatol; 2014 Feb; 29(2):330-6. PubMed ID: 24033853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Glypican-3 Expression in Hepatocellular Carcinoma by Using IDEAL IQ Magnetic Resonance Imaging.
    Chen R; Bai Y; Liu T; Zhang G; Han Y; Chen L; Gao H; Wei W; Wang M
    Acad Radiol; 2021 Aug; 28(8):e227-e234. PubMed ID: 32540197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.